VITRS Stock Overview
Provides assisted reproduction products. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Vitrolife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 220.00 |
| 52 Week High | SEK 221.00 |
| 52 Week Low | SEK 169.00 |
| Beta | 1.78 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -58.06% |
| 5 Year Change | 12.94% |
| Change since IPO | 61.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| VITRS | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.6% |
| 1Y | n/a | -24.1% | 3.1% |
Return vs Industry: Insufficient data to determine how VITRS performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how VITRS performed against the UK Market.
Price Volatility
| VITRS volatility | |
|---|---|
| VITRS Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: VITRS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine VITRS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 1,111 | Bronwyn Brophy O´Connor | www.vitrolife.com |
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems.
Vitrolife AB (publ) Fundamentals Summary
| VITRS fundamental statistics | |
|---|---|
| Market cap | SEK 31.33b |
| Earnings (TTM) | -SEK 3.80b |
| Revenue (TTM) | SEK 3.56b |
8.8x
P/S Ratio-8.2x
P/E RatioIs VITRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VITRS income statement (TTM) | |
|---|---|
| Revenue | SEK 3.56b |
| Cost of Revenue | SEK 1.49b |
| Gross Profit | SEK 2.07b |
| Other Expenses | SEK 5.87b |
| Earnings | -SEK 3.80b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | -28.10 |
| Gross Margin | 58.17% |
| Net Profit Margin | -107.03% |
| Debt/Equity Ratio | 14.6% |
How did VITRS perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-4%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/04 21:55 |
| End of Day Share Price | 2024/08/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vitrolife AB (publ) is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erik Cassel | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |
| Kallum Titchmarsh | BofA Global Research |